Comparison of theophylline and theobromine metabolism in man - PubMed (original) (raw)
Comparative Study
. 1985 Nov-Dec;13(6):725-8.
- PMID: 2867879
Comparative Study
Comparison of theophylline and theobromine metabolism in man
D J Birkett et al. Drug Metab Dispos. 1985 Nov-Dec.
Abstract
The total plasma and partial metabolic and renal clearances of theobromine and theophylline were determined in 13 healthy volunteers. Total plasma clearance for theobromine was 46% greater than that for theophylline, but the unbound clearances were almost identical. Theobromine renal clearance was 67% greater than that for theophylline but most of the difference was due to the lower protein binding of theobromine (free fraction = 0.86 compared to 0.58 for theophylline). Clearance by N-demethylation at the 3-position was 3.7-fold higher (unbound clearance 2.5-fold higher) for theobromine than for theophylline, showing that the position of the other methyl substituent (positions 1 or 7) is a major determinant of metabolic rate. There was a high degree of correlation between theophylline and theobromine plasma clearances (r = 0.86) and also between partial metabolic clearances both within drugs and across drugs (r = 0.65-0.99). The renal clearances of theophylline and theobromine were also correlated (r = 0.71). The results support the view that theophylline and theobromine are metabolized by a common group of cytochromes P-450 under similar regulatory control. Theobromine is a good model compound for assessing the activity of these enzymes in man as it has low pharmacological activity and low protein binding, its total and partial metabolic clearances correlate closely with those of theophylline, and close to 100% of the dose can be recovered as known metabolites.
Similar articles
- Influence of cimetidine, sulfinpyrazone, and cigarette smoking on theobromine metabolism in man.
Miners JO, Attwood J, Wing LM, Birkett DJ. Miners JO, et al. Drug Metab Dispos. 1985 Sep-Oct;13(5):598-601. Drug Metab Dispos. 1985. PMID: 2865110 - Disposition of caffeine and its metabolites in man.
Tang-Liu DD, Williams RL, Riegelman S. Tang-Liu DD, et al. J Pharmacol Exp Ther. 1983 Jan;224(1):180-5. J Pharmacol Exp Ther. 1983. PMID: 6848742 - Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
Teunissen MW, De Leede LG, Boeijinga JK, Breimer DD. Teunissen MW, et al. J Pharmacol Exp Ther. 1985 Jun;233(3):770-5. J Pharmacol Exp Ther. 1985. PMID: 4009489 - Human disposition and some biochemical aspects of methylxanthines.
Yesair DW, Branfman AR, Callahan MM. Yesair DW, et al. Prog Clin Biol Res. 1984;158:215-33. Prog Clin Biol Res. 1984. PMID: 6396646 Review. - Theobromine and theophylline.
Timson J. Timson J. Mutat Res. 1975;32(2):169-78. doi: 10.1016/0165-1110(75)90005-6. Mutat Res. 1975. PMID: 765793 Review.
Cited by
- Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.
Robson RA, Miners JO, Whitehead AG, Birkett DJ. Robson RA, et al. Br J Clin Pharmacol. 1987 Jun;23(6):772-5. doi: 10.1111/j.1365-2125.1987.tb03115.x. Br J Clin Pharmacol. 1987. PMID: 3606937 Free PMC article. Clinical Trial. - Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.
Lelo A, Birkett DJ, Robson RA, Miners JO. Lelo A, et al. Br J Clin Pharmacol. 1986 Aug;22(2):177-82. doi: 10.1111/j.1365-2125.1986.tb05246.x. Br J Clin Pharmacol. 1986. PMID: 3756065 Free PMC article. - Selective inhibitory effects of nifedipine and verapamil on oxidative metabolism: effects on theophylline.
Robson RA, Miners JO, Birkett DJ. Robson RA, et al. Br J Clin Pharmacol. 1988 Mar;25(3):397-400. doi: 10.1111/j.1365-2125.1988.tb03319.x. Br J Clin Pharmacol. 1988. PMID: 3358901 Free PMC article. Clinical Trial. - Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients.
Takagi K, Yamaki K, Nadai M, Kuzuya T, Hasegawa T. Takagi K, et al. Antimicrob Agents Chemother. 1991 Jun;35(6):1137-41. doi: 10.1128/AAC.35.6.1137. Antimicrob Agents Chemother. 1991. PMID: 1929255 Free PMC article. Clinical Trial. - Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E. coli.
Algharrawi KH, Summers RM, Gopishetty S, Subramanian M. Algharrawi KH, et al. Microb Cell Fact. 2015 Dec 21;14:203. doi: 10.1186/s12934-015-0395-1. Microb Cell Fact. 2015. PMID: 26691652 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources